YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1520 in its research report dated May 17, 2023.

Buy Metropolis Healthcare; target of Rs 1520: YES Securities

Metropolis Healthcare MD on AI: In 2021-22, Covid19 business was almost 20-22% of the revenue for most diagnostic companies. The non-Covid19 business is not going to grow by 22% to make it equal

AI cannot replace human knowledge: Metropolis Healthcare Promoter & MD

Stocks to watch before going into trade today.

Stocks To Watch: Bharti Airtel, Paytm, Jindal Steel & Power, Metropolis Healthcare, Jindal Stainless, Zydus

Indian indices are likely to surpass their all-time high level of 18,800 levels, with an immediate strong support at 18,200, according to Kunal Shah, the senior technical analyst at LKP Securities. The fall in crude oil prices with renewed buying activities in the auto sector supported Indian indice…

Nifty support seen at 18,200; Metropolis Healthcare and M&M top buys for coming week: Kunal Shah

Mumbai (Maharashtra) [India], April 17 (ANI/SRV): Metropolis Healthcare Limited, India’s leading diagnostic service provider announces the launch of the “NextGen HLA” Typing Test. Powered by the complex molecular technology ‘Next Generation Sequencing (NGS)‘. Metropolis’ NextGen HLA Typing is a high…

Metropolis Healthcare Limited launches the ‘NextGen HLA’ High Resolution Typing Test

Based on the OI percentage, 53 stocks including JK Cement, Metropolis Healthcare, GAIL India, Max Financial Service and Manappuram Finance witnessed a long build-up

Trade setup for Thursday: Top 15 things to know before the opening bell

Broker’s Call: Metropolis Healthcare (Buy)

NCL Industries had announced an interim dividend of Rs 1.50 per share. Today is also the record date for the same. The dividend will be paid on March 11.

Metropolis Healthcare, NCL Industries shares to go ex-dividend; Akashdeep Metal to turn ex-split

YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1720 in its research report dated February 14, 2023.

Buy Metropolis Healthcare; target of Rs 1720: YES Securities

Based on the OI percentage, 98 stocks, including AU Small Finance Bank, L&T Technology Services, Biocon, LIC Housing Finance, and Metropolis Healthcare, saw a short build-up.

Trade setup for today: Top 15 things to know before the opening bell

Based on the OI percentage, 52 stocks, including ITC, Polycab India, Metropolis Healthcare, Dr Lal PathLabs, and Marico, saw a long build-up on February 14.

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Metropolis Healthcare is a medical laboratory operator